AI-Powered PET scans could revolutionize prostate cancer treatment decisions
NCT ID NCT03594760
First seen Mar 27, 2026 · Last updated May 04, 2026 · Updated 6 times
Summary
This study aims to use advanced PSMA-PET scans combined with artificial intelligence to discover new imaging biomarkers that can predict how prostate cancer will progress and respond to treatment. Researchers will collect scan data and follow-up information from 1000 men with prostate cancer. The goal is to develop a deep learning algorithm that can help doctors personalize therapy and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'université de Montréal
RECRUITINGMontreal, Quebec, H2X 0C1, Canada
Conditions
Explore the condition pages connected to this study.